248 related articles for article (PubMed ID: 23625998)
1. The heparin-binding growth factor midkine: the biological activities and candidate receptors.
Kadomatsu K; Kishida S; Tsubota S
J Biochem; 2013 Jun; 153(6):511-21. PubMed ID: 23625998
[TBL] [Abstract][Full Text] [Related]
2. alpha4beta1- and alpha6beta1-integrins are functional receptors for midkine, a heparin-binding growth factor.
Muramatsu H; Zou P; Suzuki H; Oda Y; Chen GY; Sakaguchi N; Sakuma S; Maeda N; Noda M; Takada Y; Muramatsu T
J Cell Sci; 2004 Oct; 117(Pt 22):5405-15. PubMed ID: 15466886
[TBL] [Abstract][Full Text] [Related]
3. A receptor-like protein-tyrosine phosphatase PTPzeta/RPTPbeta binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPzeta.
Maeda N; Ichihara-Tanaka K; Kimura T; Kadomatsu K; Muramatsu T; Noda M
J Biol Chem; 1999 Apr; 274(18):12474-9. PubMed ID: 10212223
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic lymphoma kinase: "Ligand Independent Activation" mediated by the PTN/RPTPβ/ζ signaling pathway.
Deuel TF
Biochim Biophys Acta; 2013 Oct; 1834(10):2219-23. PubMed ID: 23777859
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Pleiotrophin, Midkine, Receptor Protein Tyrosine Phosphatase β/ζ, and Their Intracellular Signaling Cascades in the Nucleus Accumbens During Opiate Administration.
García-Pérez D; Laorden ML; Milanés MV
Int J Neuropsychopharmacol; 2015 Jul; 19(1):. PubMed ID: 26164717
[TBL] [Abstract][Full Text] [Related]
6. Midkine and pleiotrophin in neural development and cancer.
Kadomatsu K; Muramatsu T
Cancer Lett; 2004 Feb; 204(2):127-43. PubMed ID: 15013213
[TBL] [Abstract][Full Text] [Related]
7. The midkine family in cancer, inflammation and neural development.
Kadomatsu K
Nagoya J Med Sci; 2005 Jun; 67(3-4):71-82. PubMed ID: 17375473
[TBL] [Abstract][Full Text] [Related]
8. Expression of the heparin-binding growth factor midkine and its receptor, Ptprz1, in adult rat pituitary.
Fujiwara K; Horiguchi K; Maliza R; Tofrizal A; Batchuluun K; Ramadhani D; Syaidah R; Tsukada T; Azuma M; Kikuchi M; Yashiro T
Cell Tissue Res; 2015 Mar; 359(3):909-14. PubMed ID: 25519047
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of midkine as the basis of its pharmacological effects.
Muramatsu T
Br J Pharmacol; 2014 Feb; 171(4):814-26. PubMed ID: 23992440
[TBL] [Abstract][Full Text] [Related]
10. Midkine in the pathology of cancer, neural disease, and inflammation.
Sakamoto K; Kadomatsu K
Pathol Int; 2012 Jul; 62(7):445-55. PubMed ID: 22726064
[TBL] [Abstract][Full Text] [Related]
11. Monomeric midkine induces tumor cell proliferation in the absence of cell-surface proteoglycan binding.
Qiu L; Escalante CR; Aggarwal AK; Wilson PD; Burrow CR
Biochemistry; 2000 May; 39(20):5977-87. PubMed ID: 10821669
[TBL] [Abstract][Full Text] [Related]
12. Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types.
Stoica GE; Kuo A; Powers C; Bowden ET; Sale EB; Riegel AT; Wellstein A
J Biol Chem; 2002 Sep; 277(39):35990-8. PubMed ID: 12122009
[TBL] [Abstract][Full Text] [Related]
13. In contrast to agonist monoclonal antibodies, both C-terminal truncated form and full length form of Pleiotrophin failed to activate vertebrate ALK (anaplastic lymphoma kinase)?
Mathivet T; Mazot P; Vigny M
Cell Signal; 2007 Dec; 19(12):2434-43. PubMed ID: 17904822
[TBL] [Abstract][Full Text] [Related]
14. Receptor-type protein tyrosine phosphatase zeta as a component of the signaling receptor complex for midkine-dependent survival of embryonic neurons.
Sakaguchi N; Muramatsu H; Ichihara-Tanaka K; Maeda N; Noda M; Yamamoto T; Michikawa M; Ikematsu S; Sakuma S; Muramatsu T
Neurosci Res; 2003 Feb; 45(2):219-24. PubMed ID: 12573468
[TBL] [Abstract][Full Text] [Related]
15. The receptor protein tyrosine phosphatase (RPTP)beta/zeta is expressed in different subtypes of human breast cancer.
Perez-Pinera P; Garcia-Suarez O; Menendez-Rodriguez P; Mortimer J; Chang Y; Astudillo A; Deuel TF
Biochem Biophys Res Commun; 2007 Oct; 362(1):5-10. PubMed ID: 17706593
[TBL] [Abstract][Full Text] [Related]
16. Midkine regulates amphetamine-induced astrocytosis in striatum but has no effects on amphetamine-induced striatal dopaminergic denervation and addictive effects: functional differences between pleiotrophin and midkine.
Gramage E; Martín YB; Ramanah P; Pérez-García C; Herradón G
Neuroscience; 2011 Sep; 190():307-17. PubMed ID: 21704677
[TBL] [Abstract][Full Text] [Related]
17. Functional receptors and intracellular signal pathways of midkine (MK) and pleiotrophin (PTN).
Xu C; Zhu S; Wu M; Han W; Yu Y
Biol Pharm Bull; 2014; 37(4):511-20. PubMed ID: 24694599
[TBL] [Abstract][Full Text] [Related]
18. LDL receptor-related protein as a component of the midkine receptor.
Muramatsu H; Zou K; Sakaguchi N; Ikematsu S; Sakuma S; Muramatsu T
Biochem Biophys Res Commun; 2000 Apr; 270(3):936-41. PubMed ID: 10772929
[TBL] [Abstract][Full Text] [Related]
19. Expression of the heparin-binding growth factors Midkine and pleiotrophin during ocular development.
Cui R; Lwigale P
Gene Expr Patterns; 2019 Jun; 32():28-37. PubMed ID: 30825522
[TBL] [Abstract][Full Text] [Related]
20. Fyn is a downstream target of the pleiotrophin/receptor protein tyrosine phosphatase beta/zeta-signaling pathway: regulation of tyrosine phosphorylation of Fyn by pleiotrophin.
Pariser H; Ezquerra L; Herradon G; Perez-Pinera P; Deuel TF
Biochem Biophys Res Commun; 2005 Jul; 332(3):664-9. PubMed ID: 15925565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
